[Skip to Navigation]
February 1995

Annual Meeting of the Facial Nerve Study Group, September 19, 1994, San Diego, Calif

Author Affiliations

San Diego, Calif

Arch Otolaryngol Head Neck Surg. 1995;121(2):240. doi:10.1001/archotol.1995.01890020102022

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Prednisone is an accepted therapy for Bell's palsy. Kedar Adour, MD, Kaiser Permanente Medical Group, Oakland, Calif, discussed his theory that Bell's palsy may represent a herpes simplex virus infection. He found an improved recovery profile in individuals treated with acyclovir and prednisone compared with a group who received prednisone and a placebo.

The management of recurring facial paralysis has been a debated issue in the last several years. This entity is uncommon and probably represents recurring Bell's palsy in most cases. Jack Kartush, MD, Farmington Hills, Mich, described 14 patients with multiple recurrences of facial paralysis. Facial nerve decompression relieved the symptoms in these patients and may have a role in the management of this condition.

Barry M. Schaitkin, MD, Pittsburgh, Pa, reported on the use of botulinum toxin to reduce aberrant regeneration effects in recovering facial paralysis. He used botulinum toxin to reduce synkinesis, particularly in the area

First Page Preview View Large
First page PDF preview
First page PDF preview
Add or change institution